{"id":753695,"date":"2023-05-02T10:34:40","date_gmt":"2023-05-02T14:34:40","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-expands-tap-into-possibility-campaign-in-honor-of-mental-health-awareness-month\/"},"modified":"2023-05-02T10:34:40","modified_gmt":"2023-05-02T14:34:40","slug":"neurostar-expands-tap-into-possibility-campaign-in-honor-of-mental-health-awareness-month","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-expands-tap-into-possibility-campaign-in-honor-of-mental-health-awareness-month\/","title":{"rendered":"NeuroStar\u00ae Expands \u201cTap Into Possibility\u201d Campaign in Honor of Mental Health Awareness Month"},"content":{"rendered":"

\nCampaign features patients\u2019 experiences to support others with depression
\n<\/h2>\n
\n

\u00a0A Media Snippet accompanying this announcement is available by clicking on the image or link below:<\/a>\u00a0<\/p>\n

\n NeuroStar\u00ae Expands \u201cTap Into Possibility\u201d Campaign in Honor of Mental Health Awareness Month<\/a>\n <\/p>\n

MALVERN, Pa., May 02, 2023 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced the evolution of its “Tap Into Possibility” campaign. This year, the campaign will focus on the journey of several patients who have overcome depression and their path to recovery through NeuroStar Advanced Therapy.<\/p>\n

\u201cThe patient journey is at the heart of everything we do. We understand that depression can be debilitating, and we want to be part of the solution,\u201d said Keith J. Sullivan, President and CEO of Neuronetics. \u201cThe evolution of this campaign was based on the input of our advocate group and the concept that for depressed people, even hope is sometimes too much to hope for, but possibility is what they\u2019re looking for. By sharing stories of patients who have undergone treatment with NeuroStar TMS, we hope to inspire others to seek help and tap into their own possibilities.\u201d<\/p>\n

The \u201cTap Into Possibility\u201d campaign first launched in 2022 to raise awareness about the impact of major depressive disorder (MDD) on millions of people and the possibilities for patients after trying multiple treatment options to no avail. The new phase of the campaign will feature patient stories from Cara, Daniel, Lisa, and Jess to authentically illustrate their journey from depression to recovery:<\/p>\n